Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sodium chlorite gel for cutaneous leishmaniasis
IRCT20190714044200N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sodium chlorite in cutaneous leishmaniasis (CL), sponsored by Shiraz University of Medical Sciences. Started Sep 2020; status: completed.
02
Drugs
sodium chlorite
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20190714044200N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190714044200N2.